Interests and current limits of MALDI-TOF in clinical bacteriology

被引:0
|
作者
Degand, N. [1 ]
Ruimy, R. [2 ,3 ,4 ]
机构
[1] CHU Nice, Hop Archet 2, Bacteriol Lab, F-06202 Nice 3, France
[2] Hop Bichat Claude Bernard, AP HP, Hop Univ Paris Nord Val de Seine, Lab Bacteriol, F-75018 Paris, France
[3] Univ Paris 07, EA 3964, UFR Med Paris Diderot Paris 7, F-75877 Paris 18, France
[4] Hop Bichat Claude Bernard, Serv Biol Med, F-75877 Paris, France
关键词
MALDI-TOF; Mass spectrometry; Bacterial identification; Positive blood culture; Antibiotic resistance; Carbapenemase detection; DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; RAPID IDENTIFICATION; ROUTINE IDENTIFICATION; STAPHYLOCOCCUS-AUREUS; CULTURE-MEDIA; MYCOBACTERIA; REVOLUTION; SAMPLES;
D O I
10.1016/j.antinf.2012.07.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Until the early 2000s, in the clinical microbiology laboratories, the bacterial identification was based mainly on the biochemical analysis of phenotypic characters whose interpretation required expertise. In most cases, the results was obtained after more than 18 h. When it was taken in default, the identification was mainly obtained by molecular biology analysis such as 16S rDNA sequences. For nearly 5 years, using MALDI-TOF mass spectrometry machine revolutionized bacterial identification in clinical bacteriology laboratories. From bacterial colonies, the results of reliable identifications are easily obtained in less than 5 minutes. These advantages have greatly contributed to its success. When a laboratory is equipped by this device, the bulk of the identifications are provided by this new approach. The objective of this review is to analyze the reasons of the success of MALDI-TOF in clinical bacteriology, to know its present limitations and new applications. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 50 条
  • [41] Analysis of Microarrays by MALDI-TOF MS
    Beloqui, Ana
    Calvo, Javier
    Serna, Sonia
    Yan, Shi
    Wilson, Iain B. H.
    Martin-Lomas, Manuel
    Christian Reichardt, Niels
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (29) : 7477 - 7481
  • [42] Biomarker Characterization by MALDI-TOF/MS
    Cho, Yi-Tzu
    Su, Hung
    Wu, Wen-Jeng
    Wu, Deng-Chyang
    Hou, Ming-Feng
    Kuo, Chao-Hung
    Shiea, Jentaie
    [J]. ADVANCES IN CLINICAL CHEMISTRY, VOL 69, 2015, 69 : 209 - 254
  • [43] Applications of MALDI-TOF Spectroscopy Preface
    Liu, Shuying
    Cai, Zongwei
    [J]. APPLICATIONS OF MALDI-TOF SPECTROSCOPY, 2013, 331 : V - VI
  • [44] MALDI-TOF analysis of polystyrenes.
    Guo, BC
    Rashidzadeh, H
    Wang, YQ
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U364 - U364
  • [45] MALDI-TOF technology joins the resistance
    Parks, Lisa
    [J]. BIOANALYSIS, 2013, 5 (04) : 399 - 399
  • [46] MALDI-TOF MS in Prenatal Genomics
    Zhong, Xiao Yan
    Holzgreve, Wolfgang
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2009, 36 (04) : 263 - 272
  • [47] MALDI-TOF mass spectrometry of bacteria
    Lay, JO
    [J]. MASS SPECTROMETRY REVIEWS, 2001, 20 (04) : 172 - 194
  • [48] Studies of bacterial typing with MALDI-TOF
    Culebras, Esther
    Alvarez-Buylla, Adela
    Artacho Reinoso, M. Jose
    Antonio Lepe, Jose
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 : 42 - 46
  • [49] PiezoLC microdispenser for MALDI-TOF analysis
    Cooley, PW
    Wallace, DB
    Gooley, A
    Hopwood, F
    Svec, F
    [J]. FASEB JOURNAL, 2006, 20 (04): : A100 - A100
  • [50] Clinical Impact of Rapid Bacterial Microbiological Identification with the MALDI-TOF MS
    Uzuriaga, Miriam
    Leiva, Jose
    Guillen-Grima, Francisco
    Rua, Marta
    Yuste, Jose R.
    [J]. ANTIBIOTICS-BASEL, 2023, 12 (12):